Moderna (MRNA)

Change in Working Capital

$1.30B

TTM · Period ending: · USD

MRNA logo

MRNA Change in Working Capital

Latest reported$1.30B
MRNA TTM Change in Working Capital (-$50.31M → $1.30B)
High-resolution chart · PNG

MRNA change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
1,297,000,000
1,018,000,000
254,000,000
411,000,000
1,315,000,000
1,466,000,000
1,737,000,000
249,000,000
345,000,000
1,065,000,000
-139,000,000
-235,000,000
-1,321,000,000
-3,710,000,000
-3,455,000,000
-5,073,000,000
-4,339,000,000
-1,331,000,000
1,308,000,000
4,209,220,000
5,470,731,000
4,337,529,000
2,577,054,000
1,138,980,000
36,558,000
-24,497,000
-50,131,000
-36,990,000
-46,588,000
-22,762,000
-42,583,000
-135,531,000
-81,184,000
-104,995,500
-50,308,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.